References

References

Chronic Obstructive Airway Disorders. In: Beers MH and Berkow R. (eds). The Merck Manual of Diagnosis and Therapy, 17th ed. (online). Available at: http://www.merck.com/mrkshared/mmanual/section6/chapter68/68c.jsp. Last accessed on 22 April, 2006.

Centers for Disease Control and Prevention. National Center for Health Statistics. Report of Final Mortality Statistics. 2002.

National Heart Lung and Blood Institute. Morbidity and Mortality Chartbook. 2004.

Tillie-Leblond I, Marquette CH, Perez T, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med. 2006 Mar 21;144(6):390-6.

Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006 Mar;129(3):536-44.

National Center for Health Statistics. Raw Data from the National Health Interview Survey, U.S., 2002. Quoted in: American Lung Association. Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet. Available at:http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=35020#five. Last Accessed: 22 April, 2006.

Carroll P. Pulse Oximetry – In context. RN. September 1, 2003;66.

Littner M. “Management of Chronic Obstructive Pulmonary Disease.” In: Rakel RE and Bope ET, eds. CONN’S Current Therapy 2005, 57th ed. Philadelphia, Penn.: Elsevier Saunders; 2005.

Barnes NC, Qiu YS, Pavord ID, et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.Am J Respir Crit Care Med. 2006 Apr 1;173(7):736-43.

US Food and Drug Administration. Product Safety Alerts: Tequin (gatifloxacin). Created: February 15, 2006. Available on: http://www.fda.gov/medwatch/safety/2006/safety06.htm#chronological. Accessed on February 21, 2006. Bristol-Myers Squibb. “Dear Healthcare Provider.” February 15, 2006. Available on: http://www.fda.gov/medwatch/safety/2006/tequin_DHCP.pdf. Accessed on: February 21, 2006.

US Food and Drug Administration. FDA Public Health Advisory: Ketek (telithromycin) Tablets. Created: January 20, 2006. Available on: http://www.fda.gov/cder/drug/advisory/telithromycin.htm. Accessed on February 21, 2006.